ACTRN12614000612617终止1 期
A Phase I/II Study of the Tolerability, Safety and Pharmacokinetics of Oral Monepantel (MPL) in Individuals with Treatment-Refractory Solid Tumours.
PharmAust Limited0 个研究点目标入组 9 人开始时间: 2014年6月6日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 终止
- 发起方
- 入组人数
- 9
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Male or female patients with progressing and unresectable tumours in whom all standard treatments have been exhausted or have been contraindicated.
- •Life expectancy of at least 3 months, in the opinion of the Investigator.
排除标准
- •Recent treatment (i.e. within 14 days of screening) with any systemic anticancer therapy.
- •Participants for whom standard therapy exists, and in the view of the Invesigator, is appropriate.
- •Unresolved recovery from recent major surgery, or unresolved toxicity from recent radiotherapy.
研究者
相似试验
进行中（未招募）
不适用
A study assessing the Safety, Tolerability and Hemodynamic Effects of a Continuous 6-Hour Intravenous Infusion of CXL-1427 in Hospitalized Patients with Systolic Heart FailureHeart failure with reduced ejection fractionMedDRA version: 17.1Level: LLTClassification code 10024106Term: Left heart failureSystem Organ Class: 100000004849EUCTR2014-000771-24-DECardioxyl Pharmaceuticals, Inc.48
进行中（未招募）
1 期
A Study to Evaluate Pexidartinib for Mild to Moderate Alzheimer’s DiseaseMedDRA version: 19.0Level: LLTClassification code 10001896Term: Alzheimer's diseaseSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 19.0Level: PTClassification code 10012293Term: Dementia of the Alzheimer's type, uncomplicatedSystem Organ Class: 10029205 - Nervous system disordersAlzheimer's DiseaseEUCTR2016-000429-38-DKPlexxikon Inc.34
进行中（未招募）
1 期
A Phase 1/2 Study of the Safety, Tolerability, and Efficacy of Epacadostat in Combination With Nivolumab in Select Advanced CancersEUCTR2016-002423-29-GBincyte Corporation291
尚未招募
1 期
A Phase I study to Evaluate the Tolerability, Safety, and Immunogenicity of a PIKA-Adjuvanted Recombinant SARS-CoV-2 Spike (S) Protein Subunit Vaccine in Healthy AdultsRespiratoryPACTR202202526350870Yisheng Biopharma Singapore Co Ltd90
招募中
不适用
A Phase 1a/1b Study Exploring the Safety and Tolerability of INCB081776 in Participants With Advanced Malignancies10027656advanced maliganciesNL-OMON52063Incyte Corporation35